We are here to serve, so please don’t hesitate to contact the Oklahoma Society of Clinical Oncology with any of your questions/comments.
P.O. Box 720024
Oklahoma City, OK 73172
Become a Member
OSCO is the only professional organization that represents all oncologists, oncology nurses and oncology practices in Oklahoma. Joining OSCO gives you access to shared member resources, provides CME opportunities, and more.
Acalabrutinib-U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.